Hosted on MSN15d
Why pharma is still far from a treatment for galactosemiaGalactosemia is a rare genetic, metabolic disorder caused by a deficiency in the galactose-1-phosphate uridyltransferase (GALT). This means patients cannot break down galactose, causing a buildup of ...
Phosphate-solubilizing microorganisms (PSM ... insights for more effective utilization of PSM in ecological restoration efforts. As shown in Figure 1, This study was conducted according to the PRISMA ...
Copious expression of protein arginine methyltransferase 1 (PRMT1) is associated with poor survival in many types of cancers, including acute myeloid leukemia. We observed that a specific acute ...
This important study investigates the signaling pathways regulating retinal regeneration. Convincing evidence shows that the sphingosine-1-phosphate (S1P) signaling pathway is inhibited following ...
Department of Life Sciences, University of Trieste, via Licio Giorgieri 10, Trieste 34127, Italy Department of Agrifood, Environmental and Animal Sciences, University of Udine, via delle Scienze 206, ...
its activity drops drastically in the 3-morpholinopropane-1-sulfonic acid (MOPS) buffer and in the phosphate/citrate buffer deviating from the trend of pH profile (data not shown). This therefore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results